# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ronald Reagan (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML008-SYN
- Date: 2026-02-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margaret Ellison, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for primary care visit one month after right hip fracture repair, with dementia and caregiver assessment. **S**

## Objective

Hemoglobin: 11.1 g/dL (low); Sodium: 137 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 1.12 mg/dL; eGFR: 61 mL/min/1.73 m²; Glucose: 96 mg/dL; Calcium: 9 mg/dL; 25-hydroxyvitamin D: 16 ng/mL (low); Intact PTH: 78 pg/mL (high); Alkaline phosphatase: 134 U/L (high); Magnesium: 2 mg/dL; TSH: 2.3 mIU/L; MoCA: 11; Barthel Index: 55; GDS-15: 4. All results are synthetic.

BP 128/70 mmHg; pulse 64 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 96% on room air; weight 76 kg; BMI 22.2 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Alzheimer's disease with late onset, disclosed in 1994; Dementia due to Alzheimer's disease, moderate (FAST stage 5), with evening restlessness; Osteoporosis with right hip fragility fracture after a fall at home, repaired with internal fixation; subsequent care; History of falling; Personal history of colon cancer, operated on in 1985. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Continued without change: Donepezil 10 mg oral tablet, one tablet by mouth daily in the morning **S**
- Continued without change: Acetaminophen 500 mg oral tablet, two tablets (1,000 mg) by mouth three times daily **S**
- Stopped: Oxycodone 5 mg oral tablet, one tablet by mouth every six hours as needed for severe pain **S**
- Stopped: Diphenhydramine 25 mg oral capsule, one capsule by mouth at bedtime **S**
- Continued without change: Enoxaparin 40 mg/0.4 mL prefilled syringe, inject 40 mg under the skin daily through day 35 after surgery **S**
- Started: Cholecalciferol 50 mcg (2,000 units) oral tablet, one tablet by mouth daily **S**

## Plan

- Stop oxycodone and diphenhydramine, keep acetaminophen scheduled, and finish 35 days of enoxaparin; review every medicine against the AGS Beers Criteria at each visit. Guideline: Management of Hip Fractures in Older Adults Evidence-Based Clinical Practice Guideline (2021); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026) **S**
- Neurology consultation to stage the dementia, review donepezil benefit and its bradycardia and fall risk, and advise on evening restlessness without antipsychotics. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD) (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026) **S**
- Home physical and occupational therapy, a home safety assessment, and a CDC STEADI fall-risk check at every visit. Guideline: Management of Hip Fractures in Older Adults Evidence-Based Clinical Practice Guideline (2021); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026) **S**
- Replete vitamin D, aim for 1,000 to 1,200 mg of calcium a day from food, then obtain DXA and give intravenous zoledronic acid at about three months once calcium and kidney function are checked. Guideline: The clinician's guide to prevention and treatment of osteoporosis (2022); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026) **S**
- Monitor dementia on the CMID schedule: yearly MoCA, FAST stage, and ADL and IADL scores; neuropsychiatric screen and depression screen at follow-up. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD) (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026) **S**
- Support the caregiver: Zarit Burden Interview at the first and six-month visits, weekly respite, a home health aide, caregiver education, and Alzheimer's Association support services. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD) (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026) **S**
- Advance care planning with the patient and spouse: confirm the health care agent, discuss goals of care, and complete a POLST form; revisit at each change in stage. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD) (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026) **S**
